DexCom Inc. (NSDQ:DXCM) posted its preliminary financial results for the 4th quarter, meeting analysts’ expectations on Wall Street and sending its shares upwards.
The San Diego, Calif.-based company said it expects a total revenue of $168 million for Q4, a 28% increase from the same period in 2015, while analysts on The Street were looking for sales of $167.5 million. DexCom also said it anticipates a total revenue of $570 million for 2016, in line with the $569.8 million consensus.
Get the full story at our sister site, Drug Delivery Business News.